• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在人血小板中证实存在一种功能活跃的组织型纤溶酶原激活物(tPA)样纤溶酶原激活剂。

Demonstration of a functionally active tPA-like plasminogen activator in human platelets.

作者信息

Wang D L, Pan Y T, Wang J J, Cheng C H, Liu C Y

机构信息

Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan, ROC.

出版信息

Thromb Haemost. 1994 Apr;71(4):493-8.

PMID:8052969
Abstract

The mechanism of platelet-enhanced fibrinolysis is unclear. We therefore investigated the fibrinolytic activity of human platelets and demonstrated that they contain a tissue plasminogen activator (tPA)-like plasminogen activator, abbreviated as tPA-like-PA. This activator was detected by ELISA in platelet incubation medium and in platelet Triton extracts. Plasminogen activation assays showed that this tPA-like-PA could induce plasminogen activation to form plasmin. Western blots of Triton extracts incubated with anti-tPA antibody demonstrated a major 64-kD protein band, compared to a 70-kD band for standard single chain tPA, plus a minor 118-kD band corresponding to a complex of tPA-like-PA and plasminogen activator inhibitor (PAI-1). Western blots of Triton extracts incubated with anti-PAI-1 antibody produced an approximately similar high-molecular-weight (118 kD) protein band. Fibrin zymographic analysis of affinity-purified tPA-like-PA demonstrated a major and a minor fibrin lysis zone, which approximately corresponded to the tPA-like-PA and its complex with PAI-1 observed by Western blots. Immunogold labelling and electron microscopy demonstrated that platelet activator, either as the free form or co-localized with PAI-1, was present in granules and in channels of the open canalicular system. We conclude that platelets contain a functionally active tPA-like-PA, whose low fibrinolytic activity might be due to its readily forming a complex with PAI-1. This functionally active tPA-like-PA might contribute to the enhanced fibrinolytic activity of platelets observed in platelet-rich thrombi.

摘要

血小板增强纤维蛋白溶解的机制尚不清楚。因此,我们研究了人血小板的纤维蛋白溶解活性,并证明它们含有一种组织型纤溶酶原激活剂(tPA)样的纤溶酶原激活剂,简称为tPA样-PA。通过ELISA在血小板孵育培养基和血小板Triton提取物中检测到了这种激活剂。纤溶酶原激活试验表明,这种tPA样-PA可诱导纤溶酶原激活形成纤溶酶。用抗tPA抗体孵育的Triton提取物的Western印迹显示出一条主要的64-kD蛋白带,而标准单链tPA为70-kD带,另外还有一条次要的118-kD带,对应于tPA样-PA与纤溶酶原激活剂抑制剂(PAI-1)的复合物。用抗PAI-1抗体孵育的Triton提取物的Western印迹产生了一条大致相似的高分子量(118 kD)蛋白带。对亲和纯化的tPA样-PA进行纤维蛋白凝块酶谱分析,显示出一个主要和一个次要的纤维蛋白溶解区,这大致对应于Western印迹中观察到的tPA样-PA及其与PAI-1的复合物。免疫金标记和电子显微镜显示,血小板激活剂,无论是游离形式还是与PAI-1共定位,都存在于颗粒和开放小管系统的通道中。我们得出结论,血小板含有一种功能活跃的tPA样-PA,其低纤维蛋白溶解活性可能是由于它容易与PAI-1形成复合物。这种功能活跃的tPA样-PA可能有助于在富含血小板的血栓中观察到的血小板增强的纤维蛋白溶解活性。

相似文献

1
Demonstration of a functionally active tPA-like plasminogen activator in human platelets.在人血小板中证实存在一种功能活跃的组织型纤溶酶原激活物(tPA)样纤溶酶原激活剂。
Thromb Haemost. 1994 Apr;71(4):493-8.
2
Proteins of the fibrinolytic system in human thrombi.人类血栓中纤维蛋白溶解系统的蛋白质。
Thromb Haemost. 1996 Jan;75(1):127-33.
3
Cultured human mesangial cells produce both type 1 and type 2 plasminogen activator inhibitors.培养的人系膜细胞可产生1型和2型纤溶酶原激活物抑制剂。
Thromb Haemost. 1995 Dec;74(6):1516-20.
4
Tissue plasminogen activator in human megakaryocytes and platelets: immunocytochemical localization, immunoblotting and zymographic analysis.人巨核细胞和血小板中的组织型纤溶酶原激活剂:免疫细胞化学定位、免疫印迹和酶谱分析。
Thromb Haemost. 1988 Jun 16;59(3):529-34.
5
Hydrocortisone regulates the dynamics of plasminogen activator and plasminogen activator inhibitor expression in cultured murine keratinocytes.氢化可的松调节培养的小鼠角质形成细胞中纤溶酶原激活物和纤溶酶原激活物抑制剂表达的动态变化。
Exp Cell Res. 1998 Jul 10;242(1):110-9. doi: 10.1006/excr.1998.4065.
6
Measurement of plasminogen activator system components in plasma and tumor tissue extracts obtained from patients with breast cancer: an EORTC Receptor and Biomarker Group collaboration.乳腺癌患者血浆和肿瘤组织提取物中纤溶酶原激活物系统成分的测定:欧洲癌症研究与治疗组织(EORTC)受体与生物标志物小组合作项目
Oncol Rep. 2005 Jul;14(1):235-9.
7
Adenovirus-mediated expression and packaging of tissue-type plasminogen activator in megakaryocytic cells.腺病毒介导的组织型纤溶酶原激活剂在巨核细胞中的表达与包装
Thromb Haemost. 2001 Jun;85(6):1079-85.
8
Inhibitor-resistant tissue-type plasminogen activator: an improved thrombolytic agent in vitro.抗抑制剂组织型纤溶酶原激活剂:一种体外改良的溶栓剂。
Thromb Haemost. 1994 Jan;71(1):124-8.
9
Characterization of plasminogen activator from two human renal carcinoma cell lines.两种人肾癌细胞系纤溶酶原激活物的特性分析
J Cell Physiol. 1986 Mar;126(3):435-43. doi: 10.1002/jcp.1041260315.
10
Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysis.高度稳定的1型纤溶酶原激活物抑制剂(VLHL PAI-1)可保护纤维蛋白凝块免受组织纤溶酶原激活物介导的纤维蛋白溶解作用。
Int J Mol Med. 2007 Nov;20(5):683-7.

引用本文的文献

1
Role of Plasminogen Activation System in Platelet Pathophysiology: Emerging Concepts for Translational Applications.纤溶酶原激活系统在血小板病理生理学中的作用:转化应用的新观点。
Int J Mol Sci. 2022 May 28;23(11):6065. doi: 10.3390/ijms23116065.